How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014

I Marciano; Y Ingrasciotta; F Giorgianni; J Bolcato; A Chinellato; R Pirolo; A Di Giorgio; S Manna; V Ientile; R Gini; M Santarpia; A A Genazzani; I Uomo; M Pastorello; S W P Addario; S Scondotto; P Cananzi; R Da Cas; G Traversa; M Rossi; L Sottosanti; AP Caputi; Gianluca Trifiro

doi:10.1007/s40259-016-0175-4

How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014

I Marciano, Y Ingrasciotta, F Giorgianni, J Bolcato, A Chinellato, R Pirolo, A Di Giorgio, S Manna, V Ientile, R Gini, M Santarpia, A A Genazzani, I Uomo, M Pastorello, S W P Addario, S Scondotto, P Cananzi, R Da Cas, G Traversa, M RossiL Sottosanti, AP Caputi, Gianluca Trifiro

Medical Informatics

Research output: Contribution to journal › Article › Academic

29 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	295-306
Number of pages	12
Journal	BioDrugs
Volume	30
Issue number	4
DOIs	https://doi.org/10.1007/s40259-016-0175-4
Publication status	Published - 2016

Research programs

EMC NIHES-03-77-02

Access to Document

10.1007/s40259-016-0175-4

Cite this

Marciano, I., Ingrasciotta, Y., Giorgianni, F., Bolcato, J., Chinellato, A., Pirolo, R., Di Giorgio, A., Manna, S., Ientile, V., Gini, R., Santarpia, M., Genazzani, A. A., Uomo, I., Pastorello, M., Addario, S. W. P., Scondotto, S., Cananzi, P., Da Cas, R., Traversa, G., ... Trifiro, G. (2016). How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014. BioDrugs, 30(4), 295-306. https://doi.org/10.1007/s40259-016-0175-4

@article{d066922a5152446e815dbd68eafef7b1,

title = "How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014",

author = "I Marciano and Y Ingrasciotta and F Giorgianni and J Bolcato and A Chinellato and R Pirolo and {Di Giorgio}, A and S Manna and V Ientile and R Gini and M Santarpia and Genazzani, {A A} and I Uomo and M Pastorello and Addario, {S W P} and S Scondotto and P Cananzi and {Da Cas}, R and G Traversa and M Rossi and L Sottosanti and AP Caputi and Gianluca Trifiro",

year = "2016",

doi = "10.1007/s40259-016-0175-4",

language = "Undefined/Unknown",

volume = "30",

pages = "295--306",

journal = "BioDrugs",

issn = "1173-8804",

publisher = "Adis",

number = "4",

}

Marciano, I, Ingrasciotta, Y, Giorgianni, F, Bolcato, J, Chinellato, A, Pirolo, R, Di Giorgio, A, Manna, S, Ientile, V, Gini, R, Santarpia, M, Genazzani, AA, Uomo, I, Pastorello, M, Addario, SWP, Scondotto, S, Cananzi, P, Da Cas, R, Traversa, G, Rossi, M, Sottosanti, L, Caputi, AP & Trifiro, G 2016, 'How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014', BioDrugs, vol. 30, no. 4, pp. 295-306. https://doi.org/10.1007/s40259-016-0175-4

How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014. / Marciano, I; Ingrasciotta, Y; Giorgianni, F et al.
In: BioDrugs, Vol. 30, No. 4, 2016, p. 295-306.

Research output: Contribution to journal › Article › Academic

TY - JOUR

T1 - How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014

AU - Marciano, I

AU - Ingrasciotta, Y

AU - Giorgianni, F

AU - Bolcato, J

AU - Chinellato, A

AU - Pirolo, R

AU - Di Giorgio, A

AU - Manna, S

AU - Ientile, V

AU - Gini, R

AU - Santarpia, M

AU - Genazzani, A A

AU - Uomo, I

AU - Pastorello, M

AU - Addario, S W P

AU - Scondotto, S

AU - Cananzi, P

AU - Da Cas, R

AU - Traversa, G

AU - Rossi, M

AU - Sottosanti, L

AU - Caputi, AP

AU - Trifiro, Gianluca

PY - 2016

Y1 - 2016

U2 - 10.1007/s40259-016-0175-4

DO - 10.1007/s40259-016-0175-4

M3 - Article

SN - 1173-8804

VL - 30

SP - 295

EP - 306

JO - BioDrugs

JF - BioDrugs

IS - 4

ER -

Marciano I, Ingrasciotta Y, Giorgianni F, Bolcato J, Chinellato A, Pirolo R et al. How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014. BioDrugs. 2016;30(4):295-306. doi: 10.1007/s40259-016-0175-4